The grey squirrel warning that did the rounds in December 2025 read, at the time, like one of those seasonal filler stories that pop up every winter — a pest control company
Businesses across industries are increasingly using skill-based contests to engage customers, reward loyalty, generate leads, and create new revenue streams. Executives often assume that labelling an activity a “skill contest” is enough
More
Law firms looking to grow their client base can benefit significantly from deploying free tools designed to capture leads at the earliest stages of their marketing funnel. These tools serve a dual
More
Wall Street faces a demanding week ahead as investors navigate a Federal Reserve interest rate decision alongside a surge of high-profile corporate earnings reports. The convergence of monetary policy signals and major
More
Hargreaves Lansdown, one of the UK’s largest investment platforms, regularly publishes its weekly stock market preview to help investors prepare for key events. The weekly outlook is a widely followed guide among
More
Merck (NYSE: MRK) has unveiled a sweeping access strategy for alimatravir, an investigational once-monthly oral pill designed to prevent HIV-1 infection. The drug, also known as MK-8527, is being positioned as a
More
On July 23, President Trump issued a memorandum directing the U.S. Trade Representative to impose tariffs on goods from 60 economies found to have failed to ban imports made with forced labor.
More
Diageo (LSE: DGE) shares have endured a torrid few years, shedding more than half their value over the past three years alone. Despite that poor run, City analysts are now forecasting a
More
Alphabet and Tesla have long been considered bellwether stocks, their quarterly results often setting the tone for broader market sentiment across Wall Street. When two of the most closely watched companies in
More
Sponsorship expert Sarah Niblock argues that the scaled-down 2026 Commonwealth Games in Glasgow presents a rare and genuinely accessible opportunity for smaller brands. The 23rd Commonwealth Games is now under way in
More
On the second day of a two-day advisory meeting, FDA outside experts delivered their first rejection of the week, voting down emideltide for the 503A Bulk Drug Substances list. The FDA’s Pharmacy
More